ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

ClinicalTrials.gov ID: NCT06926660

Public ClinicalTrials.gov record NCT06926660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomised, Double-blind, Parallel-group, Multicentre, International Trial to Investigate the Safety and Efficacy of Vicadrostat and Empagliflozin Administered With Simultaneous vs Staggered Initiation in Participants With Chronic Kidney Disease at Risk of Kidney Disease Progression

Study identification

NCT ID
NCT06926660
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
416 participants

Conditions and interventions

Interventions

  • Empagliflozin Drug
  • Placebo matching vicadrostat Drug
  • Vicadrostat Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 17, 2025
Primary completion
Aug 19, 2026
Completion
Aug 19, 2026
Last update posted
Apr 27, 2026

2025 – 2026

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
Apogee Clinical Research Huntsville Alabama 35805
Orange County Clinical Trials Anaheim California 92801
North America Research Institute San Dimas California 91773
Valiance Clinical Research-Tarzana-68237 Tarzana California 91356
Amicis Research Center - Valencia Valencia California 91355
Focus Clinical Research West Hills California 91307
Clinical Research of Brandon LLC Brandon Florida 33511
Hillcrest Medical Research DeLand Florida 32720
Encore Medical Research Hollywood Florida 33024
Finlay Medical Research Corp Miami Florida 33126
Total Research Group, LLC Miami Florida 33126
San Marcus Research Clinic, Inc. Miami Lakes Florida 33014
West Orange Endocrinology Ocoee Florida 34761
Florida Kidney Physicians - Riverview/Brandon Riverview Florida 33578
Masters of Clinical Research, Inc Augusta Georgia 30909
Boise Kidney and Hypertension, PLLC Boise Idaho 83706
Research by Design, LLC Chicago Illinois 60643
Nephrology Associates of Northern Illinois and Indiana - Oak Brook Hinsdale Illinois 60521
Nephrology Associates of Northern Illinois and Indiana - Fort Wayne Fort Wayne Indiana 46804
Kansas Nephrology Research Institute, LLC Wichita Kansas 67214
Northwest Louisiana Nephrology Shreveport Louisiana 71101
Aa Mrc Llc Flint Michigan 48504
Michigan Kidney Consultants Pontiac Michigan 48341
Elixia MNA, LLC City of Saint Peters Missouri 63376
Healor Primary Care Las Vegas Nevada 89102
Endocrine Associates of Long Island Smithtown New York 11787
Durham Nephrology Associates Durham North Carolina 27704
Lucas Research, Inc. Morehead City North Carolina 28557
Brookview Hills Research Associates LLC Winston-Salem North Carolina 27103
Heritage Valley Medical Group Beaver Pennsylvania 15009
Southeast Renal Research Institute Chattanooga Tennessee 37404
Arlington Nephrology Arlington Texas 76015
Endocrine Associates Houston Texas 77004
Clinical Advancement Center, PLLC San Antonio Texas 78212
Javara Inc.-Stephenville-68996 Stephenville Texas 76401
Utah Kidney Research Institute Salt Lake City Utah 84115
Tidewater Physicians Multispecialty Group Newport News Virginia 23606

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06926660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 27, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06926660 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →